Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [4248]
News [13370]
Articles [52]
Editorials [10]
Conferences [236]
elearning [4]
Major study identifies potential new treatment targets for the most common type of bowel cancer
Major study identifies potential new treatment targets for the most common type of bowel cancer
ESMO 2026: Patients with a form of advanced lung cancer lived 56% longer without their disease progressing after receiving radiotherapy in addition to standard treatment
ESMO 2026: Patients with a form of advanced lung cancer lived 56% longer without their disease progressing after...
ESMO 2026: Perioperative apalutamide in high-risk localised or locally advanced prostate cancer substudy supports reduced risk of metastasis and death
ESMO 2026: Perioperative apalutamide in high-risk localised or locally advanced prostate cancer substudy supports...
ESMO 2026: Nearly one third of patients with advanced melanoma saw tumours disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy
ESMO 2026: Nearly one third of patients with advanced melanoma saw tumours disappear completely after receiving...
Study identifies key drivers of microbiome-linked cancer immunotherapy side effect
Study identifies key drivers of microbiome-linked cancer immunotherapy side effect
‘Molecular glue’ stabilises protein that inhibits development of non-small cell lung cancer and uterine cancer
‘Molecular glue’ stabilises protein that inhibits development of non-small cell lung cancer and uterine cancer
Six-gene scoring system could help predict leukaemia survival
Six-gene scoring system could help predict leukaemia survival
Scientists discover how cancers evade chemotherapy by entering 'Zombie-like state'
Scientists discover how cancers evade chemotherapy by entering 'Zombie-like state'
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
ESMO 2026: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer
ESMO 2026: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation